Schwab Charles Investment Management Inc. boosted its holdings in shares of Medidata Solutions Inc (NASDAQ:MDSO) by 6.3% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 347,388 shares of the company’s stock after buying an additional 20,438 shares during the period. Schwab Charles Investment Management Inc.’s holdings in Medidata Solutions were worth $22,014,000 as of its most recent SEC filing.
Other institutional investors and hedge funds have also added to or reduced their stakes in the company. Fortaleza Asset Management Inc. acquired a new position in Medidata Solutions during the third quarter worth $155,000. Polen Capital Management LLC purchased a new stake in shares of Medidata Solutions in the third quarter valued at about $205,000. Cubist Systematic Strategies LLC purchased a new stake in shares of Medidata Solutions in the second quarter valued at about $227,000. Hanseatic Management Services Inc. raised its holdings in shares of Medidata Solutions by 14,915.0% in the third quarter. Hanseatic Management Services Inc. now owns 3,003 shares of the company’s stock valued at $234,000 after purchasing an additional 2,983 shares during the last quarter. Finally, Legato Capital Management LLC purchased a new stake in shares of Medidata Solutions in the third quarter valued at about $248,000. Hedge funds and other institutional investors own 97.52% of the company’s stock.
Several analysts have recently commented on the stock. SunTrust Banks reiterated a “buy” rating and issued a $92.00 target price on shares of Medidata Solutions in a report on Friday, October 27th. Wells Fargo & Co lowered their target price on shares of Medidata Solutions from $83.00 to $80.00 and set a “market perform” rating for the company in a report on Friday, October 27th. Zacks Investment Research downgraded shares of Medidata Solutions from a “hold” rating to a “sell” rating in a report on Thursday, November 2nd. Dougherty & Co assumed coverage on shares of Medidata Solutions in a report on Thursday, November 2nd. They issued a “neutral” rating for the company. Finally, Royal Bank of Canada reiterated a “hold” rating and issued a $80.00 target price on shares of Medidata Solutions in a report on Friday, October 27th. Four investment analysts have rated the stock with a hold rating and eleven have given a buy rating to the company’s stock. The company has an average rating of “Buy” and an average target price of $82.07.
Medidata Solutions Inc (NASDAQ MDSO) opened at $67.98 on Monday. The firm has a market cap of $3,984.10, a PE ratio of 91.86, a P/E/G ratio of 3.44 and a beta of 1.58. The company has a current ratio of 1.50, a quick ratio of 3.37 and a debt-to-equity ratio of 0.20. Medidata Solutions Inc has a 1 year low of $54.36 and a 1 year high of $85.92.
Medidata Solutions (NASDAQ:MDSO) last posted its quarterly earnings results on Thursday, February 8th. The company reported $0.41 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.31 by $0.10. The company had revenue of $141.20 million during the quarter, compared to analyst estimates of $140.65 million. Medidata Solutions had a net margin of 8.14% and a return on equity of 11.59%. The firm’s revenue for the quarter was up 13.4% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.33 earnings per share. equities analysts forecast that Medidata Solutions Inc will post 0.97 EPS for the current year.
In related news, Director Carlos Dominguez sold 9,066 shares of the stock in a transaction dated Thursday, November 30th. The shares were sold at an average price of $66.85, for a total transaction of $606,062.10. Following the completion of the transaction, the director now owns 66,020 shares in the company, valued at $4,413,437. The transaction was disclosed in a document filed with the SEC, which is available through this link. Also, CFO Rouven Bergmann sold 3,000 shares of the stock in a transaction dated Wednesday, January 24th. The shares were sold at an average price of $70.00, for a total transaction of $210,000.00. Following the transaction, the chief financial officer now owns 84,775 shares of the company’s stock, valued at approximately $5,934,250. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 18,066 shares of company stock valued at $1,211,682. 5.80% of the stock is owned by company insiders.
COPYRIGHT VIOLATION WARNING: “Schwab Charles Investment Management Inc. Grows Holdings in Medidata Solutions Inc (MDSO)” was first published by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are reading this report on another domain, it was copied illegally and reposted in violation of US and international copyright laws. The correct version of this report can be accessed at https://www.dispatchtribunal.com/2018/02/19/schwab-charles-investment-management-inc-grows-holdings-in-medidata-solutions-inc-mdso.html.
Medidata Solutions Company Profile
Medidata Solutions Inc (Medidata) is a provider of cloud-based solutions for life sciences. The Company provides cloud-based solutions for clinical research in life sciences, offering platform technology that focuses on the clinical development. The Company’s plan study addresses three areas to ensure optimal study design, grant development and negotiation, and investigator payments.
Want to see what other hedge funds are holding MDSO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Medidata Solutions Inc (NASDAQ:MDSO).
Receive News & Ratings for Medidata Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medidata Solutions and related companies with MarketBeat.com's FREE daily email newsletter.